€7.5 Million Follow On Offering of Neovacs SA

Represented Maxim Group LLC as placement agent in the €7.5 million follow-on offering of Paris Alternext-listed Neovacs SA, a leader in active immunotherapies for the treatment of autoimmune diseases. The transaction was a unit offering of ordinary shares and warrant and conducted as a private placement in the United States.